1. Home
  2. RGNX vs OUST Comparison

RGNX vs OUST Comparison

Compare RGNX & OUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • OUST
  • Stock Information
  • Founded
  • RGNX 2008
  • OUST 2015
  • Country
  • RGNX United States
  • OUST United States
  • Employees
  • RGNX N/A
  • OUST N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • OUST Industrial Machinery/Components
  • Sector
  • RGNX Health Care
  • OUST Technology
  • Exchange
  • RGNX Nasdaq
  • OUST Nasdaq
  • Market Cap
  • RGNX 459.1M
  • OUST 491.7M
  • IPO Year
  • RGNX 2015
  • OUST N/A
  • Fundamental
  • Price
  • RGNX $7.62
  • OUST $11.93
  • Analyst Decision
  • RGNX Strong Buy
  • OUST Buy
  • Analyst Count
  • RGNX 12
  • OUST 6
  • Target Price
  • RGNX $36.00
  • OUST $12.83
  • AVG Volume (30 Days)
  • RGNX 1.7M
  • OUST 1.7M
  • Earning Date
  • RGNX 11-06-2024
  • OUST 11-07-2024
  • Dividend Yield
  • RGNX N/A
  • OUST N/A
  • EPS Growth
  • RGNX N/A
  • OUST N/A
  • EPS
  • RGNX N/A
  • OUST N/A
  • Revenue
  • RGNX $84,327,000.00
  • OUST $105,453,000.00
  • Revenue This Year
  • RGNX $2.34
  • OUST $35.92
  • Revenue Next Year
  • RGNX $243.67
  • OUST $30.97
  • P/E Ratio
  • RGNX N/A
  • OUST N/A
  • Revenue Growth
  • RGNX N/A
  • OUST 51.14
  • 52 Week Low
  • RGNX $7.21
  • OUST $4.65
  • 52 Week High
  • RGNX $28.80
  • OUST $16.88
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 36.08
  • OUST 67.80
  • Support Level
  • RGNX $8.06
  • OUST $8.86
  • Resistance Level
  • RGNX $10.52
  • OUST $12.07
  • Average True Range (ATR)
  • RGNX 0.76
  • OUST 1.17
  • MACD
  • RGNX -0.19
  • OUST 0.14
  • Stochastic Oscillator
  • RGNX 12.39
  • OUST 90.00

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About OUST Ouster Inc.

Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.

Share on Social Networks: